As COVID-19 began spreading across the U.S. in late February and early March, several physicians from Inova Heart and Vascular Institute (IHVI) were at the forefront of developing guidance that is now in use nationwide to direct cardiac care. “Our team’s dedication to assuring that cardiovascular patients receive timely and high quality care in a…

Read More
pink ribbon for breast cancer awareness

The COVID-19 pandemic presents clinicians with a unique set of challenges in managing breast cancer patients. As hospital resources and staff become more limited during the COVID-19 pandemic, it becomes critically important to define which breast cancer patients require more urgent care and which patients can wait for treatment until the pandemic is over. A…

Read More
pair of hands holding a brain

Dr. Mateo Ziu, medical director of the Inova Brain and Spine Tumor Program and medical director of neuro-oncology at Inova Schar Cancer Institute, was a senior author on the recent article Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. The piece contains professional guidelines for implementing a proactive and…

Read More
handshake with rubber gloves

When the American Society for Radiation Oncology (ASTRO) developed its COVID-19 professional practice guidelines, a work group of ASTRO members contributed – including Inova Schar’s Chairman and Medical Director of Radiation Oncology, Dr. Gopal Bajaj, who collaborated with fellow physicians from hospitals around the United States. The group based the guidelines on information from a…

Read More
Doctor by proton therapy machine

During radiation treatment, doctors are picking up images that could indicate COVID-19 in patients who are asymptomatic. Inova Schar Cancer Institute’s Chairman and Medical Director of Radiation Oncology, Dr. Gopal Bajaj, spoke with Bloomberg Law about how radiation oncologists are emerging as the coronavirus’s unlikely sleuths. According to the April 2020 article, there have been…

Read More

Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile.  (Originally published May 15, 2017) Bladder cancer…

Read More